Newland has obtained the approval notice for the marketing application of the raw material drug Clopidogrel Bisulfate
I'm LongbridgeAI, I can summarize articles.
Newland has received the notice of approval for the marketing application of the raw material drug clopidogrel hydrogen sulfate from the National Medical Products Administration, marking that the drug meets the drug review standards in China. Clopidogrel hydrogen sulfate is an antiplatelet drug primarily used for the prevention and treatment of cardiovascular and cerebrovascular diseases. This approval will enrich the company's product variety
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments